GlassScriptPhysician profile
Ali Shahrestani
NPI 1023200052
$25,549.76
in general payments reported to CMS, 2019-2025
10 companies · $9,900 in 2025
The $9,900 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.99 · 2020: $110 · 2021: $18.96 · 2022: $1,082 · 2023: $204 · 2024: $14K · 2025: $9,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,750.00 |
| Food and Beverage | $521.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $23,925.61 | 2024-2025 | Education, Spark, Zirconia Abutment Preparation Kit |
| Straumann USA LLC | $1,115.16 | 2022-2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $136.57 | 2020-2024 | Arestin |
| Gc America INC. | $89.85 | 2024 | Cerasmart, G-Cem, Gc Initial |
| Geistlich Pharma, North America, INC. | $64.31 | 2023 | Bio-Materials |
| Kerr Corporation | $62.85 | 2022 | |
| Nobel Biocare USA | $58.38 | 2019-2022 | |
| Philips North America LLC | $42.09 | 2019-2024 | (L00) Whitening |
| Dentsply Sirona INC | $38.95 | 2019-2023 | Suresmile |
| Solventum Corporation | $15.99 | 2025 | 3m Clinpro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Shahrestani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.